ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,805Medicare Part D Prescriptions Filled, Including Refills

Rank: 201 out of 2094

$874K Total Retail Price of All Prescriptions

Rank: 150 out of 2094

538 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,220 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METFORMIN HCL 357 334 1 8
SIMVASTATIN 333 318 2 1
OMEPRAZOLE 332 321 3 4
AMLODIPINE BESYLATE 330 322 4 2
LEVOTHYROXINE SODIUM 298 282 5 3
ATORVASTATIN CALCIUM 252 221 6 5
NEXIUM 250 246 7 16
GLIMEPIRIDE 250 231 7 31
CARVEDILOL 217 211 9 19
ZOLPIDEM TARTRATE 212 196 10 14
METOPROLOL SUCCINATE 209 199 11 9
DIOVAN 202 187 12 13
LOSARTAN POTASSIUM 200 198 13 17
DIOVAN HCT 175 171 14 28
TAMSULOSIN HCL 122 108 15 29
METOPROLOL TARTRATE 122 118 15 10
METHYLPREDNISOLONE 116 108 17 127
NAMENDA 113 113 18 32
AZITHROMYCIN 109 105 19 27
CLOTRIMAZOLE-BETAMETHASONE 106 102 20 91
LOSARTAN-HYDROCHLOROTHIAZIDE 102 94 21 52
CLOPIDOGREL 99 93 22 22
ALENDRONATE SODIUM 96 91 23 30
LISINOPRIL 96 90 23 7
ESCITALOPRAM OXALATE 94 86 25 46
LANTUS SOLOSTAR 87 85 26 76
SINGULAIR 83 75 27 64
FUROSEMIDE 82 82 28 6
ATENOLOL 82 63 28 21
PLAVIX 77 71 30 38
CRESTOR 75 72 31 15
LIPITOR 75 69 31 39
ADVAIR DISKUS 74 66 33 36
SPIRIVA 74 67 33 60
MECLIZINE HCL 74 71 33 103
PRAVASTATIN SODIUM 73 73 36 18
CELEBREX 63 62 37 74
CIPROFLOXACIN HCL 63 58 37 81
JANUMET 61 51 39 86
HYDROCHLOROTHIAZIDE 59 54 40 12
CITALOPRAM HBR 55 55 41 47
LOVAZA 55 55 41 53
BENICAR 54 54 43 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 43 55
WARFARIN SODIUM 53 53 45 11
AMOX TR-POTASSIUM CLAVULANATE 52 45 46 107
NAPROXEN 50 48 47 84
VOLTAREN 50 46 47 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.